Latent M. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies.
One third of the earths population is infected with Mycobacterium tuberculosis (Mtb), but only 5-10% of the infected individuals develop active tuberculosis (TB) over their lifetime. The remaining 90-95% stay healthy and are called latently infected individuals. They are the biggest reservoir of the tubercle bacilli and identifying the cases of latent TB is a part of the global plan of TB control. From the clinical point of view detection of latent TB infections (LTBI) in individuals with the highest active TB risk including cases of HIV infection, autoimmune inflammatory diseases or cancer, is a priority. This review summarizes the recent findings in the pathogenesis of latent TB, its diagnosis, treatment and prevention.
Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, University of Łódź, Łódź, Poland. majur@biol.uni.lodz.pl
Magdalena
M
Druszczyńska
Magdalena
M
Kowalewicz-Kulbat
Marek
M
Fol
Marcin
M
Włodarczyk
Wiesława
W
Rudnicka
D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D055985:Latent Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D014374:Tuberculin Test
D007371:Interferon-gamma